There is an increase in the survival rate of preterm infants due to ra
pid advances in medical knowledge and technology. However, the researc
h and attention paid to the proper use of pharmacotherapy in these inf
ants is still a relatively underdeveloped field. Effective and safe dr
ug therapy requires a thorough understanding of human developmental bi
ology and of the dynamic ontogeny of drug absorption, drug disposition
? drug metabolism, and drug excretion. It is apparent that maturation
of organ system function and changes in body composition during gestat
ion and during the neonatal period exert a significant effect on the d
isposition of drugs. This review focuses on the effects of maturationa
l and drug-induced changes in renal function on clinical pharmacokinet
ics in the preterm infant.